Written by Angeline A. De Leon, Staff Writer. Rutin-rich Tartary buckwheat, ‘Manten-Kirari’, significantly decreased body weight, body fat percentage, body mass index and oxidative stress markers in the seventy-three participating subjects compared to the control group.

Rutin, a plant pigment found in fruits and vegetables, is associated with a host of powerful health benefits, including antioxidant 1 anti-inflammatory, 2, and anti-diabetic effects 3. A 2006 animal study found that oral administration of rutin can significantly reduce plasma levels of lipids in diabetic rats 4, and in humans, the flavonoid shows cardioprotective effects associated with improved platelet functionality 5. In addition to being a functional food abundant in amino acids 6, Tartary buckwheat (Fagopyrum tataricum Gaertn.) is a nutrient-dense pseudo-cereal crop that contains one of the highest amounts of rutin in its seeds 7. A recent clinical trial reported that dietary intake of rutin-rich Tartary buckwheat can effectively decrease total cholesterol and markers of oxidative stress 8. A newly developed variety of Tartary buckwheat, Manten-Kirari, shows particular promise due to its high hydrophilic antioxidant capacity and less bitter taste (Ishiguro 2016). In 2016, researchers in Japan carried out a trial 9 to investigate the antioxidant effects of rutin-rich Tartary buckwheat (Manten-Kirari), as well as its potential impact on atherosclerosis and body composition.

A total of 144 subjects (aged 30 to 69 years) were enrolled in a randomized, double-blind, placebo-controlled trial in which they were randomly allocated to consume 500 mg of rutin from Manten-Kirari Tartary buckwheat in the form of noodles and cookies or an identical placebo food daily for 12 weeks. At baseline, Week 4, Week, 8, Week 12, and 3 weeks post-treatment, body composition measures were taken (body weight, BW; body mass index, BMI; body fat percentage, BFP) and fasting blood samples were collected in order to determine antioxidant markers (oxidized low-density lipoprotein, ox-LDL; thiobarbituric acid reactive substances, TBARS), lipid profile, biomarkers of liver function, and biomarkers of kidney function. Atherosclerosis Index (AI) was also calculated.

Analyses indicated that the Tartary buckwheat group had significantly greater decreases, relative to placebo, in BW (mean change = -0.35 +/- 0.82 kg vs. 0.02 +/- 1.8 kg, p = 0.030) and BMI (mean change = -0.14 +/- 0.32 kg/ m2   vs. 0.02 +/- 0.44 kg/m2 , p = 0.016) at the end of Week 8. The buckwheat group also exhibited significantly greater reduction in BFP (mean change = -0.30 +/- 2.39% vs. 0.36 +/- 1.07%, p = 0.038), compared to placebo, at the end of Week 4. Although no significant differences in ox-LDL and AI were evident between the two groups, TBARS was found to be more significantly diminished in the active test food group vs. placebo at Week 8 (mean change = -0.56 +/- 3.62 µm vs. 0.86 +/- 3.95 µm, p = 0.027).

Results of the study highlight the clinical value of rutin-rich Tartary buckwheat as a functional food with benefits for body composition, namely BW, BMI, and BFP, and antioxidant capacity, consistent with previous evidence for rutin’s free radical scavenging activity (1). Although Tartary buckwheat did not appear to exert any significant influence on lipid metabolism, liver and kidney function, or AI, its improvement of body composition was evident as early as four weeks post-treatment. Further research is warranted to elucidate the underlying mechanisms associated with Tartary buckwheat’s action, and it would be beneficial to compare the antioxidant effects of the Manten-Kirari variety of buckwheat with those of purified rutin, as a control. Clinical trials using Tartary buckwheat as part of a dietary intervention with obese individuals would also be helpful.

Source: Nishimura M, Ohkawara T, Sato Y, et al. Effectiveness of rutin-rich Tartary buckwheat (Fagopyrum tataricum Gaertn.) ‘Manten-Kirari’ in body weight reduction related to its antioxidant properties: a randomised, double-blind, placebo-controlled study. Journal of Functional Foods. 2016; 26: 460-469. DOI: 10.1016/j.jff.2016.08.004.

© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Click here to read the full text study.

Posted June 19, 2019.

Angeline A. De Leon, MA, graduated from the University of Illinois at Urbana-Champaign in 2010, completing a bachelor’s degree in psychology, with a concentration in neuroscience. She received her master’s degree from The Ohio State University in 2013, where she studied clinical neuroscience within an integrative health program. Her specialized area of research involves the complementary use of neuroimaging and neuropsychology-based methodologies to examine how lifestyle factors, such as physical activity and meditation, can influence brain plasticity and enhance overall connectivity.
 

References:

  1. Carrasco-Pozo C, Mizgier ML, Speisky H, Gotteland M. Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. Chem Biol Interact. 2012;195(3):199-205.
  2. Chua LS. A review on plant-based rutin extraction methods and its pharmacological activities. J Ethnopharmacol. 2013;150(3):805-817.
  3. Kamalakkannan N, Prince PS. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol. 2006;98(1):97-103.
  4. Stanely Mainzen Prince P, Kannan NK. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. The Journal of pharmacy and pharmacology. 2006;58(10):1373-1383.
  5. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clinica chimica acta; international journal of clinical chemistry. 1995;235(2):207-219.
  6. Jiang P, Burczynski F, Campbell C, Pierce G, Austria J, Briggs C. Rutin and flavonoid contents in three buckwheat species Fagopyrum esculentum, F. tataricum, and F. homotropicum and their protective effects against lipid peroxidation. Food Research International. 2007;40(3):356-364.
  7. Fabjan N, Rode J, Kosir IJ, Wang Z, Zhang Z, Kreft I. Tartary buckwheat (Fagopyrum tataricum Gaertn.) as a source of dietary rutin and quercitrin. J Agric Food Chem. 2003;51(22):6452-6455.
  8. Wieslander G, Fabjan N, Vogrincic M, et al. Eating buckwheat cookies is associated with the reduction in serum levels of myeloperoxidase and cholesterol: a double blind crossover study in day-care centre staffs. Tohoku J Exp Med. 2011;225(2):123-130.
  9. Nishimura M, Ohkawara T, Sato Y, et al. Effectiveness of rutin-rich Tartary buckwheat (Fagopyrum tataricum Gaertn.)‘Manten-Kirari’in body weight reduction related to its antioxidant properties: A randomised, double-blind, placebo-controlled study. Journal of functional foods. 2016;26:460-469.